Sientra Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 255
Employees
  • Stock Symbol
  • SIEN
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $2.69
  • (As of Friday Closing)

Sientra General Information

Description

Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands' OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.

Contact Information

Website
www.sientra.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Surgical Devices
Stock Exchange
NAS
Primary Office
  • 420 South Fairview Avenue
  • Suite 200
  • Santa Barbara, CA 93117
  • United States
+1 (805) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sientra Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.69 $2.78 $2.62 - $9.14 $173M 62.1M 516K -$1.24

Sientra Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 318,690 198,598 371,968 295,206
Revenue 92,167 71,241 83,699 68,126
EBITDA (76,584) (76,575) (100,098) (76,414)
Net Income (67,651) (89,947) (106,818) (82,627)
Total Assets 186,658 168,978 204,404 168,359
Total Debt 63,101 66,758 46,055 34,749
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sientra Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sientra‘s full profile, request access.

Request a free trial

Sientra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Sientra‘s full profile, request access.

Request a free trial

Sientra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel
Other Devices and Supplies
Santa Barbara, CA
255 As of 2020
00000
000000 - 000 00000

00 00000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
00000000 0000000
Dublin, Ireland
000 As of 0000
00000
0000000000 0 00000

00000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
00000000000 0000000
Alajuela, Costa Rica
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sientra Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GC Aesthetics Venture Capital-Backed Dublin, Ireland 000 00000 0000000000 0 00000
0000000000000 0000 Formerly VC-backed Alajuela, Costa Rica 000 00000 00000000 00000
00000000000 Formerly VC-backed San Jose, CA 00 000.00 000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Sientra Patents

Sientra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019302544-A1 Implant delivery system and method Pending 09-Jul-2018 00000000
CA-3105783-A1 Implant delivery system and method Pending 09-Jul-2018 00000000
EP-3820403-A1 Implant delivery system and method Pending 09-Jul-2018 00000000
US-20200008923-A1 Implant delivery system and method Pending 09-Jul-2018 00000000
US-10709851-B2 Systems, methods and devices for subcutaneous target location Active 29-Oct-2015 A61M5/427
To view Sientra’s complete patent history, request access »

Sientra Executive Team (15)

Name Title Board Seat Contact Info
Ron Menezes Director, President & Chief Executive Officer
Deborah Bettencourt Vice President, Human Resources & Corporate Administration
Richard Low Jr. Vice President, Marketing
Dan Carlisle Vice President of Innovation and Product Development
JoAnn Kuhne Vice President, Regulatory Affairs, Quality Assurance & Clinical Operations
You’re viewing 5 of 15 executive team members. Get the full list »

Sientra Board Members (11)

Name Representing Role Since
Keith Sullivan Self Board Member 000 0000
Kevin O'Boyle Sientra Board Member 000 0000
Mary Fisher Self Board Member 000 0000
Timothy Haines Self Board Member 000 0000
You’re viewing 4 of 11 board members. Get the full list »

Sientra Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sientra Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 31-Dec-2021 000000000 Buildings and Property 000 00000
0000 000000 0 07-Nov-2019 0000000000 Personal Products 0000000 0
00000 0000000 07-Nov-2019 000000000 0000 Buildings and Property
0000000 0000 25-Jul-2017 0000000000 0000 Therapeutic Devices 0000000 0
Specialty Surgical Products (Tissue Expander Portfolio) 02-Nov-2016 Corporate Asset Purchase 000 Buildings and Property 0000000 0
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Sientra Subsidiaries (2)

Company Name Industry Location Founded
Miramar Labs Therapeutic Devices Santa Clara, CA 2006
0000000 Surgical Devices Rio de Janeiro, Brazil 0000
To view Sientra’s complete subsidiaries history, request access »